Inhibikase Says FDA Clears IND For IkT-001Pro To Treat Chronic Myelogenous Leukemia

RTTNews | hace 1073
Inhibikase Says FDA Clears IND For IkT-001Pro To Treat Chronic Myelogenous Leukemia

(RTTNews) - Pharmaceutical company Inhibikase Therapeutics, Inc. (IKT) announced Friday that the U.S. Food and Drug Administration (FDA) has reviewed its Investigational New Drug (IND) application for IkT-001Pro for the treatment of Chronic Myelogenous Leukemia (CML) and issued a Study May Procced (SMP) letter.

IkT-001Pro is a prodrug formulation of imatinib mesylate and has been developed to improve the safety of the first FDA-approved Abelson (Abl) kinase inhibitor, imatinib (marketed as Gleevec).

IkT-001Pro has the potential to be a safer alternative for patients and may improve the number of patients that reach and sustain major and/or complete cytogenetic responses in stable-phase CML.

In preclinical studies, IkT-001Pro was shown to be as much as 3.4 times safer than imatinib in non-human primates, reducing burdensome gastrointestinal side effects that occur following oral administration.

Imatinib delivered as IkT-001Pro was granted Orphan Drug Designation for stable-phase CML in September, 2018.

IkT-001Pro will be evaluated in a single ascending dose bioequivalence study and will enroll approximately 64 male and female healthy volunteers aged 25 to 55 who will receive IkT-001Pro at one of four doses.

For More Such Health News, visit rttnews.com

read more
Taiwan Stock Market Tipped To Open Under Pressure On Monday

Taiwan Stock Market Tipped To Open Under Pressure On Monday

The Taiwan stock market on Friday snapped the two-day winning streak in which it had gained more than 340 points or 1.9 percent. The Taiwan Stock Exchange now sits just above the 23,430-point plateau and it's expected to see continued consolidation on Monday.
RTTNews | hace 16 minutos
Singapore Shares May Take Further Damage On Monday

Singapore Shares May Take Further Damage On Monday

The Singapore stock market had finished lower in six straight sessions, surrendering almost 120 points or 2.9 percent along the way. The Straits Times Index now sits just above the 4,150-point plateau and it's expected to open under pressure again on Monday.
RTTNews | hace 46 minutos
Malaysia Shares May Hand Back Friday's Gains

Malaysia Shares May Hand Back Friday's Gains

The Malaysia stock market has moved higher in two of three trading days since the end of the three-day losing streak in which it had fallen more than 15 points or 1 percent. The Kuala Lumpur Composite Index now sits just beneath the 1,535-point plateau although it may tick lower again on Monday.
RTTNews | hace 1h 16min
Japan Stock Market May Extend Friday's Losses

Japan Stock Market May Extend Friday's Losses

The Japan stock market headed south again on Friday, one day after ending the four-day losing streak in which it had given up almost 1,175 points or 2.8 percent. The Nikkei 225 now sits just shy of the 40,800-point plateau and it may open to the downside again on Monday.
RTTNews | hace 1h 31min
South Korea Shares May Extend Losing Streak

South Korea Shares May Extend Losing Streak

The South Korea stock market has moved lower in back-to-back sessions, tumbling more than 135 points or 3.9 percent along the way. The KOSPI now sits just shy of the 3,120-point plateau and it's likely to take further damage on Monday.
RTTNews | hace 1h 46min
Japan Monetary Base Data Due On Monday

Japan Monetary Base Data Due On Monday

Japan will on Monday release July figures for monetary base, highlighting a very light day for Asia-Pacific economic activity. In June, the base was down 3.3 percent on year.
RTTNews | hace 2h 46min